PBM (Psyence Biomedical Ltd. Common Shares) Stock Analysis

Psyence Biomedical Ltd. Common Shares (PBM) is a publicly traded Healthcare sector company. As of May 21, 2026, PBM trades at $3.89 with a market cap of $10.57M and a P/E ratio of 0.00. PBM moved +2.56% today. Year to date, PBM is -19.70%; over the trailing twelve months it is -89.32%. Its 52-week range spans $1.92 to $515.56. Rallies surfaces PBM's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

What is the latest PBM stock research?

Psyence Biomedical Ltd. Common Shares (PBM) research on Rallies includes live charts, financials, analyst ratings, hedge fund holdings, politician trades, insider activity, news, AI research, and community context. PBM moved +2.56% today.

PBM Key Metrics

Key financial metrics for PBM
MetricValue
Price$3.89
Market Cap$10.57M
P/E Ratio0.00
EPS$0.00
Dividend Yield0.00%
52-Week High$515.56
52-Week Low$1.92
Volume693
Avg Volume0
Revenue (TTM)$0
Net Income$0
Gross Margin0.00%

Latest PBM News

PBM Analyst Consensus

PBM analyst coverage data. Average price target: $0.00.

Common questions about PBM

What can I research for PBM on Rallies?
Psyence Biomedical Ltd. Common Shares (PBM) research on Rallies includes live charts, financials, analyst ratings, hedge fund holdings, politician trades, insider activity, news, AI research, and community context. PBM moved +2.56% today.
Does Rallies show live market data for PBM?
Rallies combines live market context with ticker research for PBM, including charts, news, financials, analyst data, institutional holdings, politician trades, insider activity, and AI research where available.
PBM

PBM